Ticker
NRIXCompany Name
NURIX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Inventory | Inventory to Assets Ratio |
---|---|---|---|
9/30/2025 | $ 522.47M | $ 0 | 0% |
6/30/2025 | $ 591.55M | $ 0 | 0% |
3/31/2025 | $ 615.04M | $ 0 | 0% |
12/31/2024 | $ 669.34M | $ 0 | 0% |
9/30/2024 | $ 513.6M | $ 0 | 0% |
6/30/2024 | $ 511.03M | $ 0 | 0% |
3/31/2024 | $ 312.67M | $ 0 | 0% |
12/31/2023 | $ 355.6M | $ 0 | 0% |
9/30/2023 | $ 308.19M | $ 0 | 0% |
6/30/2023 | $ 350.62M | $ 0 | 0% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Inventory / Assets
(=) Inv. to Assets
Inv. to Assets for NURIX THERAPEUTICS INC is calculated as follows: Inventory [ $ 0 ] / Assets [ $ 396.34M ]
(=) Inv. to Assets [ 0% ]
Minimum
Dec 31, 2020
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 4.46K |
---|---|
min | 0% |
max | 98.39% |
average | 6.08% |
median | 0% |
std | 11.11% |